Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gw Pharma ADR SOVEREIGN HOUSE VISION PARK HISTON CAMBRIDGE X0 CB24 9BZ GBR

www.gwpharm.com P: 44-12-2326-6800 F: 122-323-5667

Description:

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 6,864,178
Shares Outstanding, K 31,349
Annual Sales, $ 527,210 K
Annual Net Income, $ -58,130 K
Last Quarter Sales, $ 148,220 K
Last Quarter Net Income, $ -29,150 K
60-Month Beta 1.65
% of Insider Shareholders 3.10%
% of Institutional Shareholders 77.39%
Float, K 30,377
% Float 96.90%

Growth:

1-Year Return 109.97%
3-Year Return 50.00%
5-Year Return 184.55%
5-Year Revenue Growth 3,488.90%
5-Year Earnings Growth 43.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 02/16/21
Latest Earnings Date 05/10/21
Earnings Per Share ttm -1.81
EPS Growth vs. Prev Qtr 35.48%
EPS Growth vs. Prev Year -150.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GWPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 327.29
Price/Earnings to Growth N/A
Return-on-Equity % -8.00%
Return-on-Assets % -6.50%
Profit Margin % -11.03%
Debt/Equity 0.01
Price/Sales 13.04
Price/Cash Flow N/A
Price/Book 9.32
Book Value/Share 23.70
Interest Coverage -48.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar